| Date | Title | Description |
| 02.04.2025 | Brain+ announces outcome of unit rights issue | Brain+ announces outcome of unit rights issue
Wed, Apr 02, 2025 08:47 CET Report this content
Copenhagen, Denmark, 2 April 2025 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, ... |
| 31.03.2025 | Wirtek A/S: Navigating the Waters of Corporate Governance and Market Activity | In the ever-evolving landscape of corporate governance, Wirtek A/S stands as a beacon of transparency and strategic decision-making. The Danish IT services company is gearing up for its Annual General Meeting (AGM) on April 23, 2025. This m... |
| 28.03.2025 | Announcement regarding managers’ transactions in Wirtek A/S | Announcement regarding managers’ transactions in Wirtek A/S
Fri, Mar 28, 2025 08:12 CET Report this content
Company Announcement no. 4/2025
28 March 2025
Wirtek A/S has received notification pursuant to article 19 of regulation (EU) no. 596... |
| 28.03.2025 | Notice to convene Annual General Meeting in Wirtek A/S | Notice to convene Annual General Meeting in Wirtek A/S
Fri, Mar 28, 2025 08:35 CET Report this content
Company Announcement no. 5/2025
28 March 2025
Wirtek A/S (CVR-nr. 26042232) convenes the Annual General Meeting to be held completely ele... |
| 19.03.2025 | Annual Report 2024: Driving Resilient Growth Through Strategic Transformation | Annual Report 2024: Driving Resilient Growth Through Strategic Transformation
Wed, Mar 19, 2025 08:18 CET Report this content
Company Announcement no. 03/2025
19 March 2025
The consolidated annual report for the period 1 January to 31 Decem... |
| 18.03.2025 | Navigating the Financial Waters: Brain+ and Wirtek's Strategic Moves in 2025 | In the ever-evolving landscape of business, companies must adapt or risk being swept away. Two Danish firms, Brain+ A/S and Wirtek A/S, are making waves with their recent announcements. Each company is charting its course for 2025, but thei... |
| 17.03.2025 | The subscription period in Brain+’ rights issue of units begins today | The subscription period in Brain+’ rights issue of units begins today
Mon, Mar 17, 2025 08:59 CET Report this content
Copenhagen, Denmark, 17 March 2025 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION,... |
| 17.03.2025 | Wirtek announces expectations for 2025 and audited results for 2024 | Wirtek announces expectations for 2025 and audited results for 2024
Mon, Mar 17, 2025 08:39 CET Report this content
Company Announcement no. 02/2025
17 March 2025
This announcement contains inside information concerning 2025 expectations
Wi... |
| 16.03.2025 | Navigating the Future: Impero A/S and Donkey Republic's Strategic Moves in 2025 | In the ever-evolving landscape of business, companies must adapt or risk being left behind. Two Danish firms, Impero A/S and Donkey Republic, are making strategic moves that could shape their futures in 2025. Impero A/S, a player in complia... |
| 13.03.2025 | Impero A/S releases Annual Report 2024: Driven by strong traction in German speaking markets, Impero realizes 28% growth in Annual Recurring Revenue, improves EBITDA, and delivers a churn of just 2% | Impero A/S releases Annual Report 2024: Driven by strong traction in German speaking markets, Impero realizes 28% growth in Annual Recurring Revenue, improves EBITDA, and delivers a churn of just 2%
Thu, Mar 13, 2025 09:00 CET Report this c... |
| 12.03.2025 | Impero A/S releases outlook for 2025 | Impero A/S releases outlook for 2025
Wed, Mar 12, 2025 17:03 CET Report this content
Company Announcement No. 2-2025
Copenhagen, 12 March 2025
- This message contains inside information –
With reference to preliminary end of year 2024 ARR (... |
| 10.03.2025 | Change of Certified Adviser to Donkey Republic | Change of Certified Adviser to Donkey Republic
Mon, Mar 10, 2025 12:23 CET Report this content
Company Announcement no 3 - 2025
Donkey Republic hereby announces that the Company has entered into an agreement with HC Andersen Capital to take... |
| 06.03.2025 | Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million | Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million
Thu, Mar 06, 2025 08:50 CET Report this content
Copenhagen, Denmark, 6 March 2025 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR R... |
| 25.02.2025 | Mads Greiffenberg joins Wirtek as new Chief Financial Officer | Mads Greiffenberg joins Wirtek as new Chief Financial Officer
Tue, Feb 25, 2025 09:02 CET Report this content
We are pleased to announce that Mads Greiffenberg will join Wirtek as our new Chief Financial Officer (CFO), effective 1 June 2025... |
| 17.01.2025 | Impero announces improved EBITDA outlook for 2024 | Impero announces improved EBITDA outlook for 2024
Fri, Jan 17, 2025 13:08 CET Report this content
Company Announcement No. 01-2025 | Inside information
Copenhagen, 17 January 2025
Impero adjusts EBITDA outlook for 2024
In connection with pr... |
| 09.01.2025 | ExpreS2ion to Present in Upcoming Investor and Scientific Events | ExpreS2ion to Present in Upcoming Investor and Scientific Events
Thu, Jan 09, 2025 11:00 CET Report this content
Hørsholm, Denmark, 9 January 2025 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion"... |
| 30.12.2024 | Wirtek changes Certified Advisor | Wirtek changes Certified Advisor
Mon, Dec 30, 2024 08:57 CET Report this content
Company Announcement no. 18/2024
30 December 2024
As of 1 January 2025, Wirtek changes Certified Advisor to HC Andersen Capital.
Further information
Kent Moust... |
| 05.12.2024 | Grant of warrants | Grant of warrants
Thu, Dec 05, 2024 18:29 CET Report this content
Company Announcement No. 14-2024
Copenhagen, 5 December 2024
Today, Impero’s Board of Directors has decided to exercise its current authorization in section 4.8 of the Articl... |
| 15.11.2024 | Navigating Growth: A Look at MapsPeople and Impero's Q3 2024 Financial Results | In the world of business, numbers tell stories. The third quarter of 2024 has been a revealing chapter for two Danish companies, MapsPeople A/S and Impero A/S. Both firms have reported their financial results, showcasing growth, challenges,... |
| 14.11.2024 | Impero releases Q3 Report 2024: Realizes DKK 36.9M in Annual Recurring Revenue corresponding to 31% year-on-year growth and delivers positive cash flow from operating activities | Impero releases Q3 Report 2024: Realizes DKK 36.9M in Annual Recurring Revenue corresponding to 31% year-on-year growth and delivers positive cash flow from operating activities
Thu, Nov 14, 2024 08:45 CET Report this content
Company Announ... |
| 01.10.2024 | Impero A/S announces change of Certified Advisor | Impero A/S announces change of Certified Advisor
Tue, Oct 01, 2024 08:54 CET Report this content
Company Announcement No. 12-2024
Copenhagen, 1 October 2024
Impero A/S announces that the company has appointed HC Andersen Capital as new Cert... |
| 10.09.2024 | ExpreS2ion to present in upcoming investor events | ExpreS2ion to present in upcoming investor events
Tue, Sep 10, 2024 14:00 CET Report this content
Hørsholm, Denmark, 10 September 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will parti... |
| 19.10.2023 | HC Andersen Capital Events 19/10: Meet the management in OrderYoYo | HC Andersen Capital Events 19/10: Meet the management in OrderYoYo
Thu, Oct 19, 2023 08:40 CET Report this content
HC Andersen Capital is today hosting a digital event where you can meet and ask questions directly to the management. It is f... |
| 19.09.2023 | HC Andersen Capital Event 19/09: Meet the management in Qlife | HC Andersen Capital Event 19/09: Meet the management in Qlife
Tue, Sep 19, 2023 08:00 CET Report this content
HC Andersen Capital is today hosting a digital event where you can meet and ask questions directly to the management. It is free f... |
| 31.08.2023 | HC Andersen Capital Events 31/08: Explore the latest in the Nordic Life Science industry | HC Andersen Capital Events 31/08: Explore the latest in the Nordic Life Science industry
Thu, Aug 31, 2023 09:00 CET Report this content
Life Science Seminar 2023
Do you want to know more about the latest development in the Nordic Life Scie... |
| 05.06.2023 | HC Andersen Capital: Pharma Equity Group – Lifescience investment company with twofold strategy | HC Andersen Capital: Pharma Equity Group – Lifescience investment company with twofold strategy
Mon, Jun 05, 2023 09:10 CET Report this content
The investment case is driven by PEG’s ability to successfully implement and follow a twofold st... |
| 13.03.2023 | HC Andersen Capital: NeoDynamics' Management elaborates on options for long-term financing | HC Andersen Capital: NeoDynamics' Management elaborates on options for long-term financing
Mon, Mar 13, 2023 14:30 CET Report this content
Meet CEO Anna Eriksrud and CFO Aaron Wong who will elaborate on options to raise long-term capital to... |
| 28.02.2023 | Correction to 2022 annual report | Correction to 2022 annual report
Tue, Feb 28, 2023 11:11 CET Report this content
Company Announcement No. 03-2023
Copenhagen, 28 February 2023
Penneo releases financial report for the period 1 January 2022 - 31 December 2022
Correction: EBI... |
| 28.02.2023 | Penneo realizes 28% ARR growth rate in 2022 | Penneo realizes 28% ARR growth rate in 2022
Tue, Feb 28, 2023 08:32 CET Report this content
Company Announcement No. 03-2023
Copenhagen, 28 February 2023
Penneo releases financial report for the period 1 January 2022 - 31 December 2022 2022... |
| 24.02.2023 | Interim full-year report 2022: Guidance met on all parameters and EBITDA break-even for the full year | Interim full-year report 2022: Guidance met on all parameters and EBITDA break-even for the full year
Fri, Feb 24, 2023 07:59 CET Report this content
Company Announcement no. 7-23
Copenhagen, February 24, 2023
This announcement is a summary... |
| 13.02.2023 | ExpreS2ion will present fourth quarter and full-year 2022 results | ExpreS2ion will present fourth quarter and full-year 2022 results
Mon, Feb 13, 2023 16:46 CET Report this content
Hørsholm, Denmark, February 13, 2023 – ExpreS2ion Biotech Holding AB (“ExpreS2ion") is pleased to announce that it will p... |
| 09.02.2023 | HC Andersen Capital: Qlife sector update | HC Andersen Capital: Qlife sector update
Thu, Feb 09, 2023 17:00 CET Report this content
Qlife peer LumiraDX released the first survey among clinicians in the UK for POCT (Point of Care Testing) beginning of December 2022. The survey is sin... |
| 02.02.2023 | NeoDynamics Partners with Uniphar for US Distribution and Logistics | NeoDynamics Partners with Uniphar for US Distribution and Logistics
Thu, Feb 02, 2023 10:46 CET Report this content
NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the di... |
| 27.12.2022 | HC Andersen Capital: NeoDynamics – Comissioned Equity Research – Full commercialization in the US market | HC Andersen Capital: NeoDynamics – Comissioned Equity Research – Full commercialization in the US market
Tue, Dec 27, 2022 11:00 CET Report this content
Read the analysis here.
NeoDynamic's ultrasound-guided biopsy technology NeoNavia® addr... |
| 01.12.2022 | The subscription period in Audientes A/S’s rights issue of units begins today | The subscription period in Audientes A/S’s rights issue of units begins today
Thu, Dec 01, 2022 09:25 CET Report this content
Company announcement no. 31-2022
December 1, 2022
Today, 1 December 2022, is the first day of the subscription per... |
| 23.11.2022 | Curasight to present at HC Andersen Capital | Curasight to present at HC Andersen Capital
Wed, Nov 23, 2022 09:57 CET Report this content
Copenhagen, Denmark, 23 November 2022 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich... |
| 22.11.2022 | MapsIndoors delivered an ARR growth of 89% resulting in a total ARR growth of 61% | MapsIndoors delivered an ARR growth of 89% resulting in a total ARR growth of 61%
Tue, Nov 22, 2022 11:18 CET Report this content
MapsPeople A/S | Financial Report Q3 2022 | Inside Information
Company Announcement No. 18 - 2022
Aalborg, Nov... |
| 15.11.2022 | ExpreS2ion will participate in key industry and investor events | ExpreS2ion will participate in key industry and investor events
Tue, Nov 15, 2022 10:00 CET Report this content
Hørsholm, Denmark, November 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion&quo... |
| 25.08.2022 | Curasight to present at HC Andersen Capital | Curasight to present at HC Andersen Capital
Thu, Aug 25, 2022 13:43 CET Report this content
Copenhagen, Denmark, 25 August 2022 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich K... |
| 15.08.2022 | ExpreS2ion will participate in key industry and investor events | ExpreS2ion will participate in key industry and investor events
Mon, Aug 15, 2022 11:00 CET Report this content
Hørsholm, Denmark, August 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"... |
| 16.06.2022 | HC Andersen Capital Events 16/6: Meet the management in Xplora and Danish Aerospace Company | HC Andersen Capital Events 16/6: Meet the management in Xplora and Danish Aerospace Company
Thu, Jun 16, 2022 09:00 CET Report this content
HC Andersen Capital is today hosting several digital events where you can meet and ask questions dir... |
| 09.06.2022 | HC Andersen Capital Events 9/6: Meet the management in Scandinavian Medical Solutions, ExpreS2ion Biotechnologies and InDex Pharmaceuticals | HC Andersen Capital Events 9/6: Meet the management in Scandinavian Medical Solutions, ExpreS2ion Biotechnologies and InDex Pharmaceuticals
Thu, Jun 09, 2022 09:00 CET Report this content
HC Andersen Capital is today hosting digital events ... |
| 31.05.2022 | HC Andersen Capital Events 31/5: Meet the management in Omnicar | HC Andersen Capital Events 31/5: Meet the management in Omnicar
Tue, May 31, 2022 09:10 CET Report this content
HC Andersen Capital is today hosting a digital event where you can meet and ask questions directly to the top management. It is ... |
| 31.05.2022 | ExpreS2ion announces financial results for the first quarter 2022 | ExpreS2ion announces financial results for the first quarter 2022
Tue, May 31, 2022 08:30 CET Report this content
Hørsholm, Denmark, May 31, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its first quarter financial res... |
| 25.05.2022 | Additional positive preclinical proof-of-concept results for the HER2-cVLP breast cancer vaccine | Additional positive preclinical proof-of-concept results for the HER2-cVLP breast cancer vaccine
Wed, May 25, 2022 08:30 CET Report this content
Hørsholm, Denmark, May 25, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechn... |
| 25.05.2022 | HC Andersen Capital Events 25/5: Meet the management in Djurslands Bank, Xplora and Penneo | HC Andersen Capital Events 25/5: Meet the management in Djurslands Bank, Xplora and Penneo
Wed, May 25, 2022 09:00 CET Report this content
HC Andersen Capital is today hosting digital events where you can meet and ask questions directly to ... |
| 24.05.2022 | ExpreS2ion will participate in key industry and investor events | ExpreS2ion will participate in key industry and investor events
Tue, May 24, 2022 14:00 CET Report this content
Hørsholm, Denmark, May 24, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") w... |
| 18.05.2022 | Strategic partnership agreement between HC Andersen Capital and Inderes Oyj has now been formalised | Strategic partnership agreement between HC Andersen Capital and Inderes Oyj has now been formalised
Wed, May 18, 2022 11:32 CET Report this content
On 8 April 2022, HC Andersen Capital announced a strategic partnership agreement with the li... |
| 04.05.2022 | HC Andersen Capital: BoMill - Grain is a gift. Why waste a single kernel of it? | HC Andersen Capital: BoMill - Grain is a gift. Why waste a single kernel of it?
Wed, May 04, 2022 12:00 CET Report this content
Monday the 2nd of May, HC Andersen Capital held an event with BoMill, where CEO Andreas Jeppson presented an int... |
| 25.04.2022 | HC Andersen Capital Events 25/4: Meet the management in ExpreS2ion Biotechnologies and NeoDynamics | HC Andersen Capital Events 25/4: Meet the management in ExpreS2ion Biotechnologies and NeoDynamics
Mon, Apr 25, 2022 09:00 CET Report this content
HC Andersen Capital is today hosting digital events where you can meet and ask questions dire... |
| 08.04.2022 | HC Andersen Capital enters into strategic partnership and creates Nordic investor platform | HC Andersen Capital enters into strategic partnership and creates Nordic investor platform
Fri, Apr 08, 2022 07:45 CET Report this content
HC Andersen Capital has entered into a strategic partnership agreement with the listed Finish company... |
| 07.04.2022 | ExpreS2ion will participate in key industry and investor events | ExpreS2ion will participate in key industry and investor events
Thu, Apr 07, 2022 13:00 CET Report this content
Hørsholm, Denmark, April 7, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") ... |
| 31.03.2022 | HC Andersen Capital: Release of new Ascelia Pharma investment case | HC Andersen Capital: Release of new Ascelia Pharma investment case
Thu, Mar 31, 2022 09:30 CET Report this content
HC Andersen Capital releases new Ascelia Pharma investment case.
Ascelia Pharma’s Phase 3 pipeline product, Orviglance, addre... |
| 25.03.2022 | HC Andersen Capital: Release of new Agillic investment case | HC Andersen Capital: Release of new Agillic investment case
Fri, Mar 25, 2022 16:25 CET Report this content
HC Andersen Capital releases new Agillic investment case.
Agillic’s business model is a good fit for the new and changing digital ma... |
| 14.03.2022 | HC Andersen Capital: NeoDynamics - Magnus Precht on Pulse technology in the US market | HC Andersen Capital: NeoDynamics - Magnus Precht on Pulse technology in the US market
Mon, Mar 14, 2022 17:40 CET Report this content
NeoDynamics’ Magnus Precht updates us on the US market. On Tuesday 1st of March 2022, NeoDynamics filed a ... |
| 28.02.2022 | Invitation Tuesday 1/3-2022 at 11.00: Omnicar – Q4 2021 results, and update on progress with new business areas | Invitation Tuesday 1/3-2022 at 11.00: Omnicar – Q4 2021 results, and update on progress with new business areas
Mon, Feb 28, 2022 10:04 CET Report this content
Sign up here
Tune in when Omnicarservice.dk management will give deeper insights... |
| 23.02.2022 | Curasight expands its strategy and strengthen its position as a theranostic company | Curasight expands its strategy and strengthen its position as a theranostic company
Wed, Feb 23, 2022 07:00 CET Report this content
Copenhagen, Denmark, 23 February 2022 - Curasight A / S ("Curasight" or "The Company") a... |
| 18.02.2022 | HC Andersen Capital: NeoDynamics carries out a 100 percent secured rights issue of approximately SEK 69 million | HC Andersen Capital: NeoDynamics carries out a 100 percent secured rights issue of approximately SEK 69 million
Fri, Feb 18, 2022 14:30 CET Report this content
NeoDynamics has received subscription commitments from a selection of the Compan... |
| 30.12.2021 | Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital | Curasight attends the J.P. Morgan Healthcare Conference and presents at HC Andersen Capital Thu, Dec 30, 2021 08:30 CET
Curasight A/S (“Curasight” or the “Company”) CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær has been invited to ... |
| 13.12.2021 | Curasight presents at HC Andersen Capital | Curasight presents at HC Andersen Capital Mon, Dec 13, 2021 17:13 CET
Curasight A/S (“Curasight” or the “Company”) CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present a Deep Dive event in Prostate Cancer at HC Andersen Capit... |
| 07.12.2021 | Curasight A/S presents at HC Andersen Capital & Nordea Markets Virtual Growth Days seminar - 9 December 2021 | Curasight A/S presents at HC Andersen Capital & Nordea Markets Virtual Growth Days seminar - 9 December 2021 Tue, Dec 07, 2021 17:25 CET
Curasight A/S CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company and i... |
| 07.12.2021 | Carlsquare initiates research on Risk Intelligence A/S | Carlsquare initiates research on Risk Intelligence A/S Tue, Dec 07, 2021 10:48 CET
Carlsquare has today initiated coverage on behalf of Risk Intelligence A/S, and published its first report.
About Carlsquare:
Carlsquare is a Pan-European fi... |
| 29.11.2021 | ExpreS2ion will participate in key investor events in December 2021 | ExpreS2ion will participate in key investor events in December 2021 Mon, Nov 29, 2021 10:00 CET
Hørsholm, Denmark, November 29, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion") will participate and hold presentations at key investor... |
| 23.11.2021 | Curasight presents at HC Andersen Capital | Curasight presents at HC Andersen Capital Tue, Nov 23, 2021 15:10 CET
Curasight A/S (“Curasight” or the “Company”) CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the Interim Report Q3 2021 at HC Andersen Capital, 25 Nov... |
| 17.11.2021 | Q3 Interim Report 1 January – 30 September 2021 | Q3 Interim Report 1 January – 30 September 2021 Wed, Nov 17, 2021 10:56 CET
Strong growth supports the full year guidance.
Risk Intelligence A/S (“Risk Intelligence” or "Company") hereby publishes the Q3 2021 Interim Report for th... |
| 15.11.2021 | ExpreS2ion announces financial results for the third quarter of 2021 | ExpreS2ion announces financial results for the third quarter of 2021 Mon, Nov 15, 2021 12:15 CET
Hørsholm, Denmark, November 15, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its third quarter financial results for 202... |
| 15.11.2021 | ExpreS2ion announces financial results for the third quarter of 2021 | Hørsholm, Denmark, November 15, 2021 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter financial results for 2021. The report is available as an attachment and on ExpreS2ion's website (www.expres2ion... |
| 11.11.2021 | ViroGates announces its Interim Report for Q1-Q3, 2021: Revenue growth of 66% for the first nine months of 2021 | 11.11.2021 12:42:53 CET | ViroGates | Interim information
COMPANY ANNOUNCEMENT - No. 21-2021 - 11 November 2021
BIRKERØD, DENMARK – ViroGates A/S, a medical technology company developing blood tests for better triaging in hospitals to impro... |
| 30.09.2021 | ExpreS2ion will participate in key investor and industry events in October 2021 | ExpreS2ion will participate in key investor and industry events in October 2021 Thu, Sep 30, 2021 10:00 CET
ExpreS2ion Biotech Holding AB (“ExpreS2ion") will participate and hold presentations at key investor and industry events in Oct... |
| 23.08.2021 | Curasight presents at HC Andersen Capital | Curasight presents at HC Andersen Capital Mon, Aug 23, 2021 13:51 CET
Curasight A/S (“Curasight” or the “Company”) CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the Interim Report First Half 2021 at HC Andersen Capital... |
| 19.08.2021 | HC Andersen Capital initiates research on Risk Intelligence A/S | HC Andersen Capital initiates research on Risk Intelligence A/S Thu, Aug 19, 2021 10:45 CET
HC Andersen Capital has on behalf of Risk Intelligence A/S today initiated coverage with its first report.
CEO Hans Tino Hansen says:
“Our ambition ... |